Immune Response to PSF in Idiopathic vs Neuromuscular Scoliosis

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-99
SponsorAmbrish Patel

About this trial

The objective of this study is to evaluate the immune response to posterior spinal fusion (PSF) in patients with neuromuscular scoliosis, comparing patients with idiopathic scoliosis who undergo the same procedure. This will be accomplished using serum biomarkers of immune response. Anecdotally, it appears that patients with neuromuscular scoliosis have more fluid resuscitation needs compared to patients with idiopathic scoliosis. The proposed hypothesis of this observation is that patients with neuromuscular scoliosis have a more profound immune response compared to patients with idiopathic scoliosis, which leads to a more robust systematic inflammatory response syndrome.

Eligibility criteria

Qualifiers

Any patient undergoing a posterior spinal fusion, regardless of age (birth to adult)

any patient with a diagnosis of idiopathic or neuromuscular scoliosis

Disqualifiers

Patient taking immunomodulators (monoclonal antibodies, chemotherapeutic agents)

chronic steroid use

Trial design

Treatments tested in this trial

  • Serum blood samples for serum biomarkers of immune response

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ambrish Patel

Lead sponsor

Nationwide Children's Hospital

Sponsor institution